All In MedTech

Device Trial Radar · NCT06473753

Pelvic Floor Disorders in Multiple Sclerosis Patients

Clinical and Neurophysiological Assessment of Pelvic Floor Dysfunction in Patients With Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Oct 1, 2024

Primary completion

Oct 1, 2025

Study completion Oct 1, 2025

Sponsor

Lead sponsor
Assiut UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 25, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Primary objective 1. Clinical assessment of bowel, bladder, and sexual dysfunction in patients with MS 2. Impact of sphincter disorders on quality of life in patients with MS Secondary objectives -Studying the effect of low frequency rTMS on bladder symptoms in patients with MS.

Conditions

  • Multiple Sclerosis

Interventions

  • Repetitive Transcranial Magnetic StimulationDevice

    using high intensity low frequency protocol for rTMS application\[39\] for 10 sessions over two weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical assessment of bowel, bladder, and sexual dysfunction in patients with MS though applying specific related scalesTime frame: Baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Assuit university

    Asyut, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.